This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1056/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34612117
rdf:type
wikibase:Item
schema:description
บทความทางวิทยาศาสตร์ bilimsel makale 2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած article científic 2009年論文 научная статья teaduslik artikkel vetenskaplig artikel article scientific artículo científico publicado en 2009 2009年论文 2009年の論文 artigo científico (publicado na 2009) vitenskapelig artikkel مقالهٔ علمی artigo científico 2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված 2009年论文 2009年論文 naučni članak artykuł naukowy vědecký článek наукова стаття, опублікована у вересні 2009 artikull shkencor mokslinis straipsnis επιστημονικό άρθρο мақолаи илмӣ artigo científico (publicado na 2009) articol științific 2009년 논문 bài báo khoa học 2009年论文 2009 nî lūn-bûn article scientifique (publié 2009) מאמר מדעי სამეცნიერო სტატია научни чланак مقالة علمية 2009年论文 ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2009年論文 scienca artikolo vedecký článok мақолаи илмӣ videnskabelig artikel (udgivet 2009) 2009年論文 научна статия scientific article tieteellinen artikkeli artikulong pang-agham artículu científicu espublizáu en 2009 wissenschaftlicher Artikel научни чланак 2009年论文 tudományos cikk 2009年论文 articolo scientifico 2009年論文 wetenschappelijk artikel vitskapeleg artikkel سائنسی مضمون
p:P577
wds:Q34612117-AD5FDBBF-5666-4D6C-BF50-B2FA48635E3E
wdt:P577
2009-09-01T00:00:00Z
p:P407
wds:Q34612117-5FAD7F86-5C17-47AD-B31C-F24A6EC7E98C
wdt:P407
wd:Q1860
p:P2093
wds:Q34612117-A251E160-C9FF-454E-ABA1-E1F8FBA498D6 wds:Q34612117-A78501F6-313B-4DC2-A998-FD20AA506ED2 wds:Q34612117-45330452-D7D4-4022-8092-DBE3E64A4717 wds:Q34612117-516A4547-C68E-41EF-A3CE-EFD367B548AF wds:Q34612117-E9C1E886-9019-4792-A9FF-27722017AA57 wds:Q34612117-F55F0390-4056-4378-AB0D-6BB841E7015D wds:Q34612117-FAC647FC-31E3-4F75-ABAC-0EF07F784824 wds:Q34612117-AC0D8B16-91D0-451A-A295-E5624026BD01 wds:Q34612117-D0F71583-3844-4E36-B6A8-6BC0EFB8FEC8 wds:Q34612117-BC0DD2AA-9EE8-4D85-8C6A-6FD3FD161E4E wds:Q34612117-C6AB03B9-252D-4EC8-B6BF-9311C975C58A wds:Q34612117-01943EA8-4263-435A-9AB6-32FBEBA733E3 wds:Q34612117-177EE649-0E42-47AB-AAFF-D4849A686DC9 wds:Q34612117-260687D1-AE40-47ED-87AE-D490271CD426 wds:Q34612117-2F6DB94C-875A-4FDB-95E7-85FBBDEAD5FE
wdt:P2093
Edo Vellenga Carlos Graux Gert J Ossenkoppele Bart J Biemond Marie von Lilienfeld-Toal Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) German AML Study Group (AMLSG) Thomas Pabst Mojca Jongen-Lavrencic Joachim Beck Wim van Putten Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group Leo F Verdonck Marinus van Marwijk Kooy Augustin Ferrant
rdfs:label
High-dose daunorubicin in older patients with acute myeloid leukemia High-dose daunorubicin in older patients with acute myeloid leukemia High-dose daunorubicin in older patients with acute myeloid leukemia
skos:prefLabel
High-dose daunorubicin in older patients with acute myeloid leukemia High-dose daunorubicin in older patients with acute myeloid leukemia High-dose daunorubicin in older patients with acute myeloid leukemia
schema:name
High-dose daunorubicin in older patients with acute myeloid leukemia High-dose daunorubicin in older patients with acute myeloid leukemia High-dose daunorubicin in older patients with acute myeloid leukemia
p:P50
wds:Q34612117-222F79B0-6D1E-4140-B7F2-8994C2766731 wds:Q34612117-60BB0D69-C624-4EEC-9EE2-C6ADBC93FFB5 wds:Q34612117-78C9E0D0-740F-4C95-9CE7-98F3AB2314D3 wds:Q34612117-8E475B61-A526-44E3-A8D5-C6FA7E1CCC39 wds:Q34612117-97287702-774E-4E4F-876D-951D4B24C7E9 wds:Q34612117-D851F625-A380-4CAE-B5F3-449272B280CF wds:Q34612117-DD0AEAF8-04EA-4CB9-8A7E-CDDD32C166A3
wdt:P50
wd:Q37067755 wd:Q89490552 wd:Q71513060 wd:Q66385451 wd:Q19859713 wd:Q73546936 wd:Q89534570
p:P1476
wds:Q34612117-71B7D8B7-8CF6-4394-A12D-2A177147FBD9
wdt:P1476
High-dose daunorubicin in older patients with acute myeloid leukemia
p:P304
wds:Q34612117-4F5C296A-97DE-4FAF-B0E1-C77BC1A8B7C3
wdt:P304
1235-1248
p:P31
wds:Q34612117-DBA68518-977B-4E8C-BC51-6D77092F6CC9
wdt:P31
wd:Q13442814
p:P921
wds:Q34612117-34520599-404B-465E-82D1-867AB9B4AAA5 wds:Q34612117-36E00281-BFFC-4E90-9ECD-8D14DCA664F0
wdt:P921
wd:Q411659 wd:Q29496
p:P698
wds:Q34612117-B92FAD77-7DA8-4EDB-B892-18C49A912B95
wdtn:P698
n10:19776405
wdt:P698
19776405
p:P1433
wds:Q34612117-60BE66DD-C2BB-498C-947A-283266D85A79
wdt:P1433
wd:Q582728
p:P433
wds:Q34612117-96FEE8AE-2E7A-4038-BEF5-F5F932A5FF94
p:P478
wds:Q34612117-ACB9E9E8-BCC5-4236-B088-B4DD0AE1920A
wdt:P433
13
wdt:P478
361
p:P1104
wds:Q34612117-21CACEEC-4954-4ABC-9A76-BE04D8F52B77
wdt:P1104
14
p:P356
wds:Q34612117-499C0DEF-2063-4177-BCF7-74FA54A6EE05
wdtn:P356
n12:NEJMOA0901409
wdt:P356
10.1056/NEJMOA0901409